Physiologically based pharmacokinetic modeling in neonates: Current status and future perspectives
Rational drug use in special populations is a clinical problem that doctors and pharma-cists
must consider seriously. Neonates are the most physiologically immature and vulnerable to …
must consider seriously. Neonates are the most physiologically immature and vulnerable to …
Current and future physiologically based pharmacokinetic (PBPK) modeling approaches to optimize pharmacotherapy in preterm neonates
Introduction There is a need for structured approaches to inform on pharmacotherapy in
preterm neonates. With their proven track record up to regulatory acceptance …
preterm neonates. With their proven track record up to regulatory acceptance …
Desorption electrospray ionization mass spectrometry imaging allows spatial localization of changes in acetaminophen metabolism in the liver after intervention with 4 …
Acetaminophen (APAP) overdose is the most common cause of acute liver failure in the US,
and hepatotoxicity is initiated by a reactive metabolite which induces characteristic …
and hepatotoxicity is initiated by a reactive metabolite which induces characteristic …
From immature pharmacotherapy towards pharmacotherapy of the immature
K Allegaert, JN van den Anker - Seminars in Fetal and Neonatal Medicine, 2022 - Elsevier
To truly attain effective and safe pharmacotherapy, the similarities and dissimilarities in
physiology between micro-preemies and extreme preterm infants should be explored. The …
physiology between micro-preemies and extreme preterm infants should be explored. The …
The Impact of Low Cardiac Output on Propofol Pharmacokinetics across Age Groups—An Investigation Using Physiologically Based Pharmacokinetic Modelling
Background: pathophysiological changes such as low cardiac output (LCO) impact
pharmacokinetics, but its extent may be different throughout pediatrics compared to adults …
pharmacokinetics, but its extent may be different throughout pediatrics compared to adults …
Evaluation of urinary acetaminophen metabolites and its association with the genetic polymorphisms of the metabolising enzymes, and serum acetaminophen …
K Sridharan, M Al Jufairi, E Al Ansari, A Jasim… - Xenobiotica, 2021 - Taylor & Francis
Acetaminophen is gaining importance as a first-line drug for treating patent ductus arteriosus
(PDA) in neonates. Predominant metabolites of acetaminophen in preterm neonates vary …
(PDA) in neonates. Predominant metabolites of acetaminophen in preterm neonates vary …
Investigating the impact of dose banding and oral formulations of paracetamol in pediatrics: A pharmacokinetic simulation-based safety assessment study
J Rosenqvist - 2024 - diva-portal.org
Paracetamol, a widely used analgesic and antipyretic drug, can be found in various
formulations and doses for both home and hospital use. The aim of this study was to …
formulations and doses for both home and hospital use. The aim of this study was to …
[DOC][DOC] Current and future physiology-based pharmacokinetic (PBPK) modeling approaches to optimize pharmacotherapy in preterm neonates.
K Allegaert, MY Abbasi, P Annaert, O Olafuyi… - pure.eur.nl
Introduction: There is a need for structured approaches to inform on pharmacotherapy in
preterm neonates. With their proven track record up to regulatory acceptance …
preterm neonates. With their proven track record up to regulatory acceptance …
The Protective Potential of 4-Methylpyrazole (4MP) against Acetaminophen (APAP) Overdose
JY Akakpo - 2021 - search.proquest.com
Drug-induced liver injury (DILI) is a prominent health concern and a major challenge for
drug development worldwide. One of the most common causes of DILI in the developed …
drug development worldwide. One of the most common causes of DILI in the developed …